Cargando…
MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection
MV140 is a mucosal vaccine of inactivated whole bacteria (E. coli, K. pneumoniae, E. faecalis, P. vulgaris) with clinical efficacy against recurrent urinary tract infections (UTIs). Here, MV140 was evaluated in a murine model of acute uropathogenic E. coli (UPEC)-induced UTI using the UTI89 strain....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275044/ https://www.ncbi.nlm.nih.gov/pubmed/37333312 http://dx.doi.org/10.21203/rs.3.rs-2992611/v1 |
_version_ | 1785059829767733248 |
---|---|
author | Saz-Leal, Paula Ligon, Marianne M. Diez-Rivero, Carmen M. García-Ayuso, Diego Mohanty, Soumitra Conejero, Laura Brauner, Annelie Subiza, José L. Mysorekar, Indira U. |
author_facet | Saz-Leal, Paula Ligon, Marianne M. Diez-Rivero, Carmen M. García-Ayuso, Diego Mohanty, Soumitra Conejero, Laura Brauner, Annelie Subiza, José L. Mysorekar, Indira U. |
author_sort | Saz-Leal, Paula |
collection | PubMed |
description | MV140 is a mucosal vaccine of inactivated whole bacteria (E. coli, K. pneumoniae, E. faecalis, P. vulgaris) with clinical efficacy against recurrent urinary tract infections (UTIs). Here, MV140 was evaluated in a murine model of acute uropathogenic E. coli (UPEC)-induced UTI using the UTI89 strain. MV140 vaccination resulted in UPEC clearance, concomitant with increased influx of myeloid cells in urine, CD4+ T cells in the bladder, and a systemic adaptive immune response to both MV140-containing E. coli and UTI89. |
format | Online Article Text |
id | pubmed-10275044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-102750442023-06-17 MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection Saz-Leal, Paula Ligon, Marianne M. Diez-Rivero, Carmen M. García-Ayuso, Diego Mohanty, Soumitra Conejero, Laura Brauner, Annelie Subiza, José L. Mysorekar, Indira U. Res Sq Article MV140 is a mucosal vaccine of inactivated whole bacteria (E. coli, K. pneumoniae, E. faecalis, P. vulgaris) with clinical efficacy against recurrent urinary tract infections (UTIs). Here, MV140 was evaluated in a murine model of acute uropathogenic E. coli (UPEC)-induced UTI using the UTI89 strain. MV140 vaccination resulted in UPEC clearance, concomitant with increased influx of myeloid cells in urine, CD4+ T cells in the bladder, and a systemic adaptive immune response to both MV140-containing E. coli and UTI89. American Journal Experts 2023-06-07 /pmc/articles/PMC10275044/ /pubmed/37333312 http://dx.doi.org/10.21203/rs.3.rs-2992611/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Article Saz-Leal, Paula Ligon, Marianne M. Diez-Rivero, Carmen M. García-Ayuso, Diego Mohanty, Soumitra Conejero, Laura Brauner, Annelie Subiza, José L. Mysorekar, Indira U. MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection |
title | MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection |
title_full | MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection |
title_fullStr | MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection |
title_full_unstemmed | MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection |
title_short | MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection |
title_sort | mv140 mucosal bacterial vaccine improves uropathogenic e. coli clearance in an experimental model of urinary tract infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275044/ https://www.ncbi.nlm.nih.gov/pubmed/37333312 http://dx.doi.org/10.21203/rs.3.rs-2992611/v1 |
work_keys_str_mv | AT sazlealpaula mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT ligonmariannem mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT diezriverocarmenm mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT garciaayusodiego mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT mohantysoumitra mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT conejerolaura mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT braunerannelie mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT subizajosel mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection AT mysorekarindirau mv140mucosalbacterialvaccineimprovesuropathogenicecoliclearanceinanexperimentalmodelofurinarytractinfection |